Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

47.66
BATS BZX Real-Time Price
As of 2:27pm ET
 -1.51 / -3.07%
Today’s Change
46.52
Today|||52-Week Range
137.05
-57.51%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close49.17
Today’s open48.03
Day’s range46.52 - 49.66
Volume33,307
Average volume (3 months)662,214
Market cap$1.9B
Dividend yield--
Data as of 2:27pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-76.00%
Earnings growth (this year)-46.62%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-2.59-5.99%
GLPGGalapagos NV-1.04-2.03%
GWPHGW Pharmaceuticals P...+2.82+3.38%
IRWDIronwood Pharmaceuti...+0.03+0.25%
Data as of 2:28pm ET, 06/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$1.44
Annual revenue (last year)$0.00
Annual profit (last year)-$145.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

Partner Offers

Search for Jobs